tiprankstipranks
Advertisement
Advertisement
Climb Bio price target raised to $12 from $9 at Baird
PremiumThe FlyClimb Bio price target raised to $12 from $9 at Baird
21d ago
Climb Bio price target raised to $12 from $9 at Baird
Premium
The Fly
Climb Bio price target raised to $12 from $9 at Baird
22d ago
Climb Bio initiated with an Outperform at Wedbush
Premium
The Fly
Climb Bio initiated with an Outperform at Wedbush
22d ago
Climb Bio outlines 2026 clinical milestones and cash runway
PremiumCompany AnnouncementsClimb Bio outlines 2026 clinical milestones and cash runway
3M ago
Climb Bio announces pipeline progress, priorities for FY26
Premium
The Fly
Climb Bio announces pipeline progress, priorities for FY26
3M ago
Climb Bio Challenges Alumis Milestone and Royalty Obligations
Premium
Company Announcements
Climb Bio Challenges Alumis Milestone and Royalty Obligations
3M ago
Climb Bio, Inc. Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsClimb Bio, Inc. Reports Q3 2025 Financial Results
5M ago
Climb Bio reports Q3 EPS (19c) vs (13c) last year
Premium
The Fly
Climb Bio reports Q3 EPS (19c) vs (13c) last year
5M ago
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors
Premium
Company Announcements
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100